0001729214-18-000001.txt : 20180125 0001729214-18-000001.hdr.sgml : 20180125 20180125111430 ACCESSION NUMBER: 0001729214-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: 4a5 FILED AS OF DATE: 20180125 DATE AS OF CHANGE: 20180125 EFFECTIVENESS DATE: 20180125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XORTX Therapeutics Inc. CENTRAL INDEX KEY: 0001729214 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-304059 FILM NUMBER: 18547294 BUSINESS ADDRESS: STREET 1: SUITE 2400 - 745 THURLOW STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 0C5 BUSINESS PHONE: 403-607-2621 MAIL ADDRESS: STREET 1: SUITE 2400 - 745 THURLOW STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 0C5 D 1 primary_doc.xml X0708 D LIVE 0001729214 XORTX Therapeutics Inc. SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6E 0C5 403-607-2621 BRITISH COLUMBIA, CANADA APAC Resources Inc. None Corporation true Allen Davidoff Suite 2400 - 745 Thurlow Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 0C5 Executive Officer Director President & CEO Alan Moore Suite 2400 - 745 Thurlow Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 0C5 Director Bruce Rowlands Suite 2400 - 745 Thurlow Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 0C5 Director John Meekison Suite 2400 - 745 Thurlow Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 0C5 Executive Officer CFO Other Decline to Disclose 06b 4a5 false 2018-01-10 false true true true true Issuer completed a financing separate from the business combination transaction. 0 505283 505283 0 false 1 0 0 0 false XORTX Therapeutics Inc. /s/ Allen Davidoff Allen Davidoff President & CEO 2018-01-25